ABSTRACT 7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(napthalen-2-ylmetyl)-4,5,-dihydro-1H-benzo [b][1,4]diazepin-2(3H)-one (Bz-423) is a proapoptotic 1,4-benzodiazepine that potently suppresses disease in the murine model of lupus by selectively killing pathogenic lymphocytes. In MRL/MpJ-Fas lpr (MRL-lpr) mice, Bz-423 overcomes deficient expression of the Fas death receptor and hyperactivation of antiapoptotic phosphatidylinositol 3-kinase (PI3K)-Akt signaling to specifically kill pathogenic CD4 ϩ T cells. Bz-423 binds to the oligomycin-sensitivity-conferring protein component of the mitochondrial F 0 F 1 -ATPase, which modulates the enzyme leading to formation of superoxide by the mitochondrial respiratory chain. Scavenging this reactive oxygen species blocks all subsequent components of the apoptotic cascade. To gain insight into how apoptotic signaling activated by Bz-423-induced superoxide contributes to the selective depletion of MRL-lpr CD4 ϩ T cells, we characterized the death mechanism in a CD4 ϩ T cell leukemia line (Jurkat). Although Bz-423-induced superoxide indirectly inactivates Akt, this response is not required for T cell death. Apoptosis instead results from parallel increases in levels of the proapoptotic Bcl-2 proteins Noxa and Bak leading to specific activation of Bak, mitochondrial outer membrane permeabilization, and a commitment to apoptosis. By directly up-regulating proteins that trigger loss of mitochondrial outer membrane integrity, Bz-423 bypasses defective Fas function and antiapoptotic PI3K-Akt signaling in MRL-lpr CD4 ϩ T cells. Moreover, because disease-associated abnormalities should sensitize autoreactive CD4 ϩ T cells to transcriptional up-regulation of Noxa by redox signals and to Bak-dependent apoptosis, the apoptotic mechanism elucidated in Jurkat cells provides important clues into the cell-type-and disease-selective effects of Bz-423 in MRLlpr mice.
Human and murine lupus is mediated by autoreactive lymphocytes that survive abnormally and are chronically activated because of persistent stimulation with endogenous autoantigens (Hoffman, 2004; Santiago-Raber et al., 2004) . Bz-423 is a proapoptotic 1,4-benzodiazepine with therapeutic properties in murine models of lupus that are linked to specific apoptosis of disease-causing lymphocytes (Blatt et al., 2002; Bednarski et al., 2003) . In MRL/MpJ-Fas lpr (MRL-lpr) mice, Bz-423 selectively kills splenic CD4 ϩ T cells, which is the lymphoid subset responsible for disease in this model (Bednarski et al., 2003) . Treatment is not associated with opportunistic infections, and Bz-423 does not reduce lymphocyte numbers or alter immune function in normal mice, which indicates that this agent is not globally immunosuppressive.
Bz-423 binds to the oligomycin-sensitivity-conferring protein subunit of the mitochondrial F 0 F 1 -ATPase, which induces a state 3-to-state 4 respiratory transition and promotes formation of superoxide (O 2 . ) by the mitochondrial respiratory chain (Johnson et al., 2005) . Bz-423-induced O 2 . functions as mitochondria intermembrane space (MIS), collapse of the mitochondrial electrochemical gradient (⌬ m ), and activation of caspases (Blatt et al., 2002) . In isolated mitochondria, Bz-423 increases O 2 . , but collapse of ⌬ m and cytochrome c release are not observed (Blatt et al., 2002 (Blatt et al., , 2008 . These data demonstrate that extramitochondrial factors couple . to cytochrome c release.
Differences in the factors that mediate return of the apoptotic signal to mitochondria should contribute to the selectivity of Bz-423 for pathogenic versus normal lymphocytes and other cell types. In relatively resistant cell types, such as mouse embryonic fibroblasts (MEFs), apoptosis signal-regulating kinase1 (ASK1) was identified as a critical upstream cellular redox sensor linking . to apoptosis (Blatt et al., 2008) . Activation of ASK1 initiates a mitogenactivated protein (MAP) kinase cascade culminating in the activation of c-Jun N-terminal kinase (JNK). Activated JNK is then necessary for activation of the proapoptotic Bcl-2 proteins Bax and Bak resulting in mitochondrial outer membrane permeabilization (MOMP) and a commitment to apoptotic cell death, as a small-molecule JNK inhibitor prevents these steps. In contrast, Bz-423-induced O 2 . does not activate the ASK1-JNK pathway in more sensitive Ramos B cells (Blatt et al., 2009) . Instead, degradation of the antiapoptotic Bcl-2 family protein Mcl-1 and functional activation of proapoptotic BH3-only proteins link the O 2 . signal to activation of Bax and Bak in this B cell line. Accumulation of activated CD4 ϩ T cells in MRL-lpr mice results from defects in Fas-death receptor signaling along with hyperactivation of the prosurvival PI3K-Akt pathway (Barber et al., 2005) . To understand how signaling activated by Bz-423 overcomes antiapoptotic signals in MRL-lpr CD4 ϩ T cells and leads to their selective depletion, we elucidated the death mechanism in a CD4 ϩ T cell leukemia line (Jurkat). We selected Jurkat cells for these studies because they are amenable to genetic manipulation and constitutive activation of Akt in this line mimics hyperactivated PI3K-Akt signaling in MRL-lpr CD4 ϩ T cells (Astoul et al., 2001) . Although . indirectly inactivates Akt and activates JNK in Jurkat cells, neither response is required for cell death. Rather, Bz-423-induced T cell death depends on a parallel apoptotic cascade marked by increased levels of the proapoptotic Bcl-2 proteins Noxa and Bak leading to preferential activation of Bak. Collectively, these data suggest that selective killing is mediated by the induction of Noxa and Bak in sensitive cell types and not in cells that are resistant to Bz-423, such as fibroblasts. Integrating knowledge of the apoptotic signaling network activated by Bz-423 in T cells with properties of autoreactive T lymphocytes provides new insight into why modulation of the F 0 F 1 -ATPase with Bz-423 leads to specific apoptosis of MRL-lpr CD4 ϩ T cells.
Materials and Methods
Reagents. Manganese(III)meso-tetrakis(4-benzoic acid)porphyrin (MnTBAP) was purchased from Alexis Biochemicals (San Diego, CA). Dihydroethidium (DHE) was obtained from Invitrogen (Carlsbad, CA). SP600125 was purchased from EMD Biosciences (San Diego, CA). Bz-423 was synthesized as described previously (Bunin et al., 1994) . All other reagents were purchased from Sigma-Aldrich (St. Louis, MO).
Cell Lines and Culture. Jurkat cells were provided by V. Castle (University of Michigan), and were maintained in RPMI 1640 medium supplemented with fetal bovine serum (10%), penicillin (100 U/ml), streptomycin (100 g/ml), and L-glutamine (300 g/ml). In vitro experiments were conducted in media containing 2% FBS. Organic compounds were dissolved in media containing 0.5% dimethyl sulfoxide.
Transient Transfections. Small interfering RNA molecules (siRNAs) targeting Bax, Bak, or Noxa were purchased from Dharmacon RNA Technologies (Layfayette, CO) as siGENOME SMARTpool reagents. J. C. Rathmell (Duke University Medical School) provided the plasmid-encoding myrAkt. Cells were washed once with ice-cold phosphate-buffered saline (PBS), suspended in electroporation buffer T (Amaxa Biosystems, Gaithersburg, MD) at a density of 7.5 ϫ 10 6 cells/ml, and subjected to electroporation with the desired siRNA (2 g) or plasmid (8 g) with an Amaxa Nucleofector apparatus and a 2.0-mm electroporation cuvette with use of program G-16. Cells were transfected once daily for 2 days. Three days after the initial transfection, cellular extracts were prepared or cells were incubated with Bz-423.
Detection of Cell Death, DNA Content, O 2 . , and ATP Levels.
Cell viability and apoptotic DNA fragmentation were assessed as described previously (Blatt et al., 2002 Preparation of Cellular Extracts. Cellular lysates were prepared as described previously (Blatt et al., 2002) . Mitochondrial and cytosolic extracts were isolated by digitonin permeabilization followed by differential centrifugation as described previously (Blatt et al., 2002) . Immunoblotting with antibodies specific for the cytosolic protein GAPDH or the mitochondrial proteins Hsp60 or the ␤-subunit of the F 0 F 1 -ATPase (V-␤) was used to evaluate the purity of cytosolic and mitochondrial fractions. Total protein content in cellular lysates or mitochondrial/cytosolic fractions was evaluated by the Bradford protein assay (Bio-Rad Laboratories, Hercules, CA).
Immunoblot Analysis. Cellular lysates or mitochondrial/cytosolic fractions were separated by SDS-polyacrylamide gel electrophoresis, and transferred to polyvinylidene difluoride membranes as described previously (Blatt et al., 2002) . Membranes were blocked by use of skim milk powder (5% w/v) in PBS containing Tween (0.05% v/v) (Fig. 1B) , which is consistent with activation of the intrinsic (mitochondrial) apoptotic pathway. Once in the cytosol, cytochrome c and Smac/DIABLO promote caspase activation by initiating apoptosome formation or displacing inhibitor of apoptosis proteins from caspases, respectively (Danial and Korsmeyer, 2004) . As predicted by release of these proapoptotic MIS proteins, cleavage of the caspase-3 substrate PARP is detected at 8 h (Fig. 1C, inset ). These events are followed by apoptotic DNA fragmentation (data not shown) and a loss of plasma membrane integrity indicative of cell death (Fig. 1C) .
Preincubation of Jurkat cells with MnTBAP, a cell-permeable porphyrin possessing superoxide dismutase activity (Ohse et al., 2001) , reduces . (Fig. 1D ), blocks release of cytochrome c and Smac/DIABLO (Fig. 1B) , and inhibits cell death ( Fig. 1 , A and E). The fact that MnTBAP prevents Bz-423-induced apoptosis argues that, unlike some inhibitors of the F 0 F 1 -ATPase (e.g., oligomycin), which significantly deplete ATP and trigger necrosis (Watabe and Nakaki, 2007) , modulation of the F 0 F 1 -ATPase by Bz-423 primarily affects O 2 . . Consistent with this expectation, Bz-423 did not alter ATP levels before the release of proapoptotic MIS proteins (Fig. 1F ). Given the essential role of O 2 . in
Bz-423-induced T cell apoptosis, antioxidant levels and mechanisms should affect the sensitivity of T cells to this agent. Hence, the reduced levels of glutathione present in MRL-lpr CD4 ϩ T cells relative to normal murine T cells provides one possible basis to explain their sensitivity to Bz-423 (Bobé et al., 2006) .
Bak Activation Is Essential for Bz-423-Induced T Cell Apoptosis. Because release of proapoptotic MIS proteins is a key apoptotic checkpoint (Danial and Korsmeyer, 2004) , differences in the mediators coupling O 2
. to loss of mitochondrial outer membrane integrity should also contribute to the selectivity of Bz-423. MOMP is a process often mediated by two multidomain proapoptotic Bcl-2 proteins, Bax and Bak (Youle and Strasser, 2008) . In its inactive state, Bax is present in the cytosol, whereas inactive Bak is localized to the mitochondrial outer membrane (Youle and Strasser, 2008) . In response to apoptotic stimuli, Bax translocates to mitochondria, and undergoes a conformational change that leads to homo-oligomerization and formation of high-molecular-weight channels in the mitochondrial outer membrane (Youle and Strasser, 2008) . Immunoblotting cytosolic and mitochondrial fractions from Bz-423-treated Jurkat cells reveals redistribution of Bax from the cytosol to the mitochondria ( Fig. 2A) . This change occurs after 8 h, which is significantly delayed relative to appearance of cytochrome c and Smac/DIABLO in the cytosol at 4 h (Fig. 1B) . Although Bz-423 induces Bax translocation in Jurkat cells, it cannot account for the observed MOMP.
In contrast, activation of Bak does not involve subcellular redistribution, but is associated with a conformational change and exposure of a cryptic N-terminal domain that can be detected by immunofluorescence (Youle and Strasser, 2008) . Bak activation is observed in 31 Ϯ 5% of cells within 4 h and 63 Ϯ 10% of cells by 8 h (Fig. 2B ). In agreement with the immunoblotting data, active Bax was detected by immunofluorescence only after 8 h, at which time 28 Ϯ 3% of cells were positive (Fig. 2B) . Pretreating Jurkat cells with MnTBAP blocked activation of both Bax and Bak (Supplemental Fig. 1 ). These data indicate that .
signals activation of Bak in a time frame consistent for it to cause MOMP. To test whether either Bax or Bak are necessary for Bz-423-induced T cell apoptosis, expression of these proteins was reduced by use of siRNAs (Fig. 3A) . Knockdown of Bax (Ͼ99%) did not block Bz-423-induced cell death, whereas reduction of Bak expression (Ͼ90%) blunted apoptosis, increasing the EC 50 for Bz-423-induced cell death Ͼ2-fold (Fig.  3B) . Knockdown of Bax along with Bak provided no additional protection compared with reduction of only Bak (Fig.  3B) . Intracellular O 2 . levels were increased equivalently by Bz-423 in Bak knockdown and control cells after 1 h (Fig. 3C) , which indicates that reducing Bak levels does not prevent Bz-423-induced O 2 . production. In contrast, release of cytochrome c and Smac/DIABLO, as well as the downstream cleavage of PARP was suppressed in Jurkat cells with reduced levels of Bak (Fig. 3D) . Together, these results indicate that activation of Bak links Bz-423-induced O 2 . with loss of mitochondrial outer membrane integrity and apoptosis. Recent studies show that activation of Bax can be caspasedependent (Kepp et al., 2007; Lakhani et al., 2006) . Because Bak is required for Bz-423-induced MOMP and caspase activation, we hypothesized that Bax activation might be blocked by knockdown of Bak. As expected, reduction of Bak expression blocked Bax activation, whereas Bax knockdown increased the fraction of cells staining positive for active Bak (Supplemental Fig. 2 ). In addition, activation of Bax is blocked by preincubation of Jurkat cells with the pan-caspase inhibitor zVAD-fmk, whereas Bak activation and cytochrome c release are still observed (Fig. 4, A and B) . These data support a hierarchical model in which Bak mediates MOMP, whereas Bax is activated by a subsequent, caspase-dependent process. Although cytochrome c release is still observed, zVAD-fmk prevents downstream consequences of caspase activation such as apoptotic DNA fragmentation (Fig. 4C) . To determine whether inhibiting caspase activation blocks Bz-423-induced killing, Jurkat cells were treated with a concentration of Bz-423 ϾEC 50 for cell death along with zVAD-fmk for 24 h, at which point Bz-423 was removed and cultures replenished with zVAD-fmk. Although caspase inhibition prevented Bz-423-induced cell death (i.e., loss of plasma membrane integrity) after 24 h, no viable cells remained after 5 days (Fig. 4D) In MEFs, activation of the cytosolic redox-sensor ASK1 is the response most proximal to the O 2 . signal (Blatt et al., 2008) .
Activated ASK1 then initiates a MAP kinase cascade that culminates in phosphorylation and activation of JNK, a proapoptotic kinase that promotes Bax and Bak activation through several mechanisms (Weston and Davis, 2007) . In contrast, Bz-423-induced O 2 . does not activate ASK1-JNK signaling in B cells (Blatt et al., 2009) . To determine whether the ASK1-JNK pathway is engaged in T cells, phospho-JNK was measured in Bz-423-treated Jurkat cells. Although Bz-423 activates JNK in Jurkat cells (increasing phospho-JNK levels as in Fig. 5A ), it occurs significantly later relative to the kinetics observed in MEFs (4 h versus 0.5 h). These results suggest that Jurkat cells actively restrict activation of JNK by ROS. The prosurvival kinase Akt is constitutively active in Jurkat cells as an indirect consequence of defects in the expression of the lipid phosphatases, phosphatase and tensin homolog and SH2-containing inositol phosphatase, which render PI3K activity unopposed, increasing levels of phosphatidylinositol triphosphates (Astoul et al., 2001 ). Binding of Akt to phosphatidylinositol triphosphates results in a conformational change that promotes phosphorylation and activation of Akt (Hanada et al., 2004) . O 2 . -dependent inactivation (dephosphorylation) of Akt occurs in Jurkat cells treated with 2-methoxyestradiol, an estrogen-metabolite proposed to inhibit superoxide dismutases (Gao et al., 2005) . Likewise, . also caused a decrease in phospho-Akt levels that coincides with JNK activation at 4 h (Fig. 5A) . The timing of Bz-423-induced Akt dephosphorylation and JNK activation coincides with MOMP, allowing for the possibility that these responses may signal Bak activation. To explore this hypothesis, we first excluded that these changes are downstream of and dependent on MOMP (Fig. 5B) . Despite the inability to undergo apoptosis, Bz-423-induced Akt dephosphorylation and JNK activation were observed to an equivalent or greater extent, respectively, in Bak knockdown cells versus control (Fig. 5B) . Preincubation with MnTBAP blocked changes in phospho-Akt levels and suppressed JNK activation (Fig. 5C ). Unlike MEFs, pretreating Jurkat cells with a JNK-selective kinase inhibitor (SP600125; Bennett et al., 2001) , which prevented phosphorylation of the JNK substrate activating transcription factor 2 (data not shown), did not block Bz-423-induced apoptosis (Fig. 5D ). This finding indicates that in Jurkat cells, . activates other proapoptotic mechanisms that run in parallel with JNK signaling. Because Akt promotes survival by inhibitory phosphorylation of proapoptotic proteins, including the BH3-only protein Bad, caspase-9, and ASK1 (Hanada et al., 2004) , inhibition of Akt can cause cell death (Maurer et al., 2006) . Given that Bz-423 inactivates Akt, we asked whether Akt inhibition is necessary for Bz-423-induced T cell apoptosis. To test this hypothesis, Jurkat cells were transiently transfected with a dominant, constitutively active myristoylated form of Akt (myrAkt) that bypasses the need for upstream activating signals that are redox-sensitive (Gao et al., 2005) . PhosphoAkt levels were unaltered in transfected cells in the presence of Bz-423, whereas JNK activation was reduced by Ͼ60% (Fig. 5E) , which argues that inhibition of Akt by Bz-423 is necessary for JNK activation. Despite preserving Akt activity, the myrAkt construct failed to block Bz-423-induced apoptosis (Fig. 5F ). Thus, although Bz-423 inactivates Akt and activates JNK, other parallel processes couple O 2 . to Bakmediated MOMP in Jurkat cells. Activation of Bak during Bz-423-Induced T Cell Apoptosis. Bak activation is restrained by binding to the antiapoptotic Bcl-2 proteins Bcl-x L and Mcl-1 (Willis et al., 2005) . Because . signals degradation of Mcl-1 in B cells (Blatt et al., 2009) , we sought to determine whether a similar mechanism contributes to activation of Bak in Jurkat cells. Although levels of Bcl-x L were stable, Mcl-1 was reduced by Bz-423 to Ͻ50% of control levels after 4 h, and continued to fall to Ͻ10% by 8 h (Fig. 6A) . The decrease in Mcl-1 is concentration-dependent, and is blocked by MnTBAP (Fig.  6B) . As in B cells, Bz-423 causes O 2 . -dependent reduction in
Mcl-1 within a time frame coincident with activation of Bak in T cells.
Mcl-1 is controlled by a variety of transcriptional and posttranslational mechanisms (Warr and Shore, 2008) . For example, binding of the BH3-only protein Noxa to Mcl-1 displaces Bak and targets Mcl-1 for proteasomal degradation (Willis et al., 2005) . Levels of Noxa are elevated Ͼ3-fold in Jurkat cells treated with Bz-423 for 2 h (Fig. 6A) . It is interesting that siRNA knockdown of Noxa by Ͼ99% in- jpet.aspetjournals.org creased the EC 50 for cell death by ϳ40% (Fig. 6C) , and decreased Bak activation by ϳ50% (Fig. 6D) . These data indicate that the increase in Noxa levels contributes to, but is not solely responsible for, activation of Bak.
Forced expression of Noxa can be insufficient to trigger apoptosis unless combined with a BH3-only protein (e.g., Bad) capable of disrupting Bak ⅐ Bcl-x L complexes (Willis et al., 2005 ). Therefore, we tested whether Bz-423 changes the concentration of other BH3-only proteins that could contribute to Bak activation by neutralizing Bcl-x L . Bz-423 did not increase levels of the BH3-only proteins Bad, Bik, Bim, Bmf, and Puma or promote activation of Bid (Fig. 6A) .
Although Bak is typically activated by increases in levels of BH3-only proteins relative to antiapoptotic Bcl-2 proteins (Youle and Strasser, 2008) , increased Bak expression induced by some proapoptotic stimuli including ROS can also contribute to Bak activation (Chirakkal et al., 2006; Fei et al., 2008) . As seen in Fig. 6A , Bak levels increase Ͼ2-fold within 2 h of Bz-423 treatment, and continue to rise to Ͼ5-fold above control levels at 8 h, whereas Bax levels remain unchanged. The increase in both Noxa and Bak is blocked by MnTBAP (Fig. 6B) , which directly links these responses to O 2 . . In sum,
these data suggest a model in which activation of Bak results from neutralization of Mcl-1 by increased Noxa, which, together with an absolute increase in Bak protein levels, overcomes Bcl-x L -dependent cell survival (Fig. 6E ).
Discussion
The apoptotic mechanism of Bz-423 was characterized in Jurkat cells as a means to understand the cell-type-and disease-selective apoptosis in MRL-lpr mice. In all cell types examined, activation of Bax and/or Bak is required for . to cause cytochrome c release. However, the signaling pathway leading to activation of these proapoptotic Bcl-2 family proteins differs between resistant cell types (e.g., MEFs) and lymphocytes. In fibroblasts, Bz-423-induced apoptosis depends on signals transmitted through JNK, which is activated within 30 min via a MAP kinase cascade initiated by ASK1 (Blatt et al., 2008) . Bz-423-induced O 2 . does not engage the ASK1-JNK pathway in Ramos B cells; instead Bax/Bak-dependent apoptosis is mediated by functional activation of BH3-only proteins in this cell type (Blatt et al., 2009) . Although JNK is activated in Bz-423-treated Jurkat cells, it is not necessary for apoptosis and its activation is delayed relative to the timing defined in MEFs. We reason that absence of an early JNK response in Jurkat cells probably results from suppression of ASK1 activation by constitutively active Akt (Astoul et al., 2001; Zhang et al., 2005) . Consistent with this hypothesis, constitutive activation of Akt by use of a myrAkt construct suppresses JNK activation in Jurkat cells. The fact that neither JNK activation nor Akt inhibition are necessary for Jurkat cell death argues that, in T lymphocytes, Bz-423 activates additional proapoptotic signaling in parallel to these responses. The pathway leading to apoptosis in Jurkat cells is associated with increased levels of Noxa and Bak. These increases are first detected at 2 h, which is before both MOMP and JNK activation. This observation suggests that up-regulation of Noxa and Bak are key components of the JNK-independent apoptotic signaling that links . to MOMP in Jurkat cells. Because free, uncomplexed Bak adopts an active conformation once available binding sites on Bcl-x L and Mcl-1 are saturated (Willis et al., 2007) , further increase of Bak levels causes MOMP. Noxa potentiates this process by both displacing Bak from Mcl-1 and targeting Mcl-1 for proteasomal degradation (Willis et al., 2005) . Hence, neutralization of Mcl-1 by Noxa in the absence of increased Bcl-x L levels, allows Bak to overcome Bcl-x L -mediated cell survival on the basis of its increased stoichiometry (Fig. 6E) . This model is consistent with several recent reports demonstrating that neutralization of Mcl-1 and Bcl-x L is sufficient to activate Bak and trigger apoptosis even in the presence of high levels of Bcl-2 (Kepp et al., 2007; Kutuk et al., 2009; Willis et al., 2005 Willis et al., , 2007 . with disease-specific apoptotic signaling in the target cell population. The apoptotic mechanism uncovered in Jurkat cells provides several lines of reasoning to understand the basis for the selectivity of Bz-423 against autoreactive T cells in MRLlpr mice. First, because MRL-lpr CD4 ϩ T cells possess aberrantly low glutathione levels (Bobé et al., 2006) , they have a reduced capacity to decompose . compared with normal murine T cells. Moreover, lymphocytes display low activities of antioxidant enzymes (e.g., superoxide dismutases) relative to most other cells types (Van Remmen et al., 1999) . Together, these effects predict increased sensitivity to Bz-423 because all components of the death cascade are O 2 . -dependent.
Second, defective Fas signaling and chronic T cell antigen receptor stimulation in MRL-lpr lymphocytes can lead to increased transcriptional induction of Noxa by redox signals and enhanced sensitivity to Bak-dependent apoptosis, respectively. MRL-lpr CD4 ϩ T cells express supraphysiological levels of Fas ligand (FasL) because of failed negative regulation (Bobé et al., 1997) . A key transcriptional activator of both FasL and Noxa is forkhead box 3a, a forkhead transcription factor that is activated by ROS (Kavurma and Khachigian, 2003; Nakamura and Sakamoto, 2008; Obexer et al., 2007) . Hence, elevated basal levels of forkhead box 3a in MRL-lpr CD4 ϩ T cells should cause exaggerated transcriptional up-regulation of Noxa in response to . . Moreover, persistent stimulation of lupus T cells by endogenous autoantigens down-regulates costimulatory CD28 signaling thereby limiting expression of Bcl-x L (Bertsias et al., 2009; Vallejo, 2005) . The combination of low levels of Bcl-x L and increased Noxa should selectively sensitize MRLlpr CD4 ϩ T cells to Bz-423 relative to both normal lympho- jpet.aspetjournals.org cytes and resistant cell types such as MEFs. Moreover, earlier findings that Bz-423 selectively reduces CD4 ϩ T cells without affecting CD8 ϩ T cells in MRL-lpr mice are consistent with the fact that Noxa does not mediate activationinduced cell death in CD8 ϩ T cells (Fischer et al., 2008) . Finally, inactivation of Akt by Bz-423 blocks a primary pathway required for abnormal survival and activation of T lymphocytes in MRL-lpr mice. Previous work has shown that the PI3K-Akt signaling axis is hyperactivated in MRL-lpr CD4 ϩ T cells and inhibition of this pathway specifically reduces this lymphoid subset via increased apoptosis, similar to the effects of Bz-423 (Barber et al., 2005) . Because inactivation Akt is not required for Bz-423-induced apoptosis in Jurkat cells, other signaling mechanisms must couple O 2 . to activation of Bak in this model. Nevertheless, these results do not exclude the possibility that inactivation of Akt contributes to the selective killing of CD4 ϩ T cells by Bz-423 in MRL-lpr mice.
Modulation of the mitochondrial F 0 F 1 -ATPase leads to potent therapeutic responses in murine models of lupus linked to specific apoptosis of disease-causing lymphocytes. Intersections between the apoptotic-signaling network activated by modulation of the F 0 F 1 -ATPase with Bz-423 in Jurkat cells and specific disease-associated characteristics of autoreactive T cells provides an understanding of the basis for selective killing of pathogenic CD4 ϩ T cells in MRL-lpr mice. Other immune diseases and certain neoplastic conditions possess similar phenotypic changes that should sensitize them to the mechanism identified here (Rommel et al., 2007; Samuels et al., 2004) . Such observations suggest that development of small molecule modulators of the F 0 F 1 -ATPase based on the Bz-423 pharmacophore may have broad therapeutic potential (Hong and Pedersen, 2008) .
